Where does Taris Biomedical LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Taris Biomedical LLC ranks #6,389 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Taris Biomedical LLC hold?

Taris Biomedical LLC holds 53 US utility patents granted between 2015 and 2025, spanning 13 technology areas.

What is Taris Biomedical LLC's Innovation Score?

Taris Biomedical LLC has an Innovation Score of 44.4 out of 100 (top 26% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Taris Biomedical LLC focus on?

Taris Biomedical LLC's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 48 patents, ranking #456 of 7,163 assignees active in that subclass. Grants appear in 13 CPC subclasses total.

Is Taris Biomedical LLC's patent grant rate increasing or decreasing?

Taris Biomedical LLC's recent grant velocity is +67% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Taris Biomedical LLC's patents?

Taris Biomedical LLC's patents average 22.4 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Taris Biomedical LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Taris Biomedical LLC

USPTO PatentsView assignee record - 53 granted patents across 13 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Taris ranks #6,389 of 49,997 tracked US assignees by granted-patent volume, with 53 patents across 13 technology areas.

#6,389
of 49,997 US assignees by volume: Top 26%
by Innovation Score (44.4/100): 22.4
avg claims per patent: +67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6389 · US Corporation #6,389 · 53 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 53 grants
UPPER-Q #6,389/49,997
PHOTO-FINISH Shoretel
CPC-FOCUS A61K · 13 areas
INNOV-PAR 44.4/100
CLAIMS-DENSE 22.4 claims/avg
TYPE-USCORP US Corporation
VEL-SURGE +67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Shoretel, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Taris’s 44.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.8 pts (31%) Velocity 4.4 pts (10%) Breadth 12.7 pts (29%) Claim depth 13.5 pts (30%)

Qualcomm Incorporated · highest

85
CYTONOME/ST · near

44
Pivotal Commware · near

44
Qeexo · near

44
Taris Biomedical · this assignee

44
Tokyo Metropolitan… · near

44
3D Lighting… · lowest

7

What this shows Taris's Innovation Score is 44.4/100 (top 26% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Taris?

Each dot is one of Taris’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Taris’s own 22.4 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Taris vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Taris's grants concentrate

Taris Biomedical LLC is a focused PatentsView assignee: 13 CPC subclasses with 90.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (9 grants) versus a trough of 2 in 2015. By volume, Taris sits between Shoretel, Inc. and Transocean Sedco Forex Ventures Limited.

Taris's three-year grant acceleration

From 2019–2021 to 2022–2024, Taris Biomedical LLC moved from 21 to 14 grants (0.67x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Shoretel

53
Solaria

53
Suprema

53
Takara BIO

53
Tenga

53
Thine

53
TPI Composites

53
Transocean Sedco…

53
Taris Biomedical ◀

53

What this shows Taris holds 53 patents at rank #6,387, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Taris

By rank, the assignees closest to #6,387 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Taris's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Taris, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Taris ranks #456 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

CYTONOME/ST, LLC 44 Pivotal Commware, Inc. 44 Tokyo Metropolitan University 44 Qeexo, Co. 44

Similar claim depth

Nearest assignees by average claims per patent (22.4 here).

Idorsia Pharmaceuticals Ltd 22.4 avg NthDegree Technologies Worldwide Inc 22.4 avg Cylance Inc. 22.4 avg Sion Power Corporation 22.5 avg

Taris's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 26% higher than 74% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Taris Biomedical LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	3.8%
2016	3	5.7%
2017	3	5.7%
2018	5	9.4%
2019	5	9.4%
2020	7	13.2%
2021	9	17.0%
2022	3	5.7%
2023	4	7.5%
2024	7	13.2%
2025partial year	5	9.4%

Which technologies does Taris Biomedical LLC patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 48

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 46

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 25

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 10

B65B - Machines, Apparatus OR Devices FOR, OR Methods OF, Packaging Articles OR MATERIALS; Unpacking 7

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

B29L - Indexing Scheme Associated With Subclass B29c, Relating TO Particular Articles 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

B29K - Indexing Scheme Associated With Subclasses B29b, B29c OR B29d, Relating TO Moulding Materials OR TO Materials FOR ; Moulds, ; Reinforcements, Fillers OR Preformed Parts, e.g. Inserts 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Y10T - Technical Subjects Covered BY Former US Classification 1

Top 13 of 13 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Taris Biomedical LLC's patent record in context - here's where to go next.

Taris Biomedical LLC's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 90.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #6,389 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Taris Biomedical LLC against Shoretel, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 44.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.